FOXP3 and neoplasm: We, therefore, tested if immunomodulation with SA-4-1BBL affects the conversion of conventional CD4+ T cells into CD4+CD25+FoxP3+ T cells in the tumor microenvironment and peripheral lymphoid tissues.